Jemperli
dostarlimab
Listed by GlaxoSmithKline LLC
- Strength
- 50 mg/mL
- Form
- Injection
- Route
- Intravenous
- Class
- Programmed Death Receptor-1 Blocking Antibody
What it contains
- Dostarlimab 50 mg/mL
FDA record
| Dosage form | Injection |
|---|---|
| Route | Intravenous |
| Drug class | Programmed Death Receptor-1 Blocking Antibody |
| Approval route | BLA — biologic licence |
| NDC code | 0173-0898 |
| FDA application | BLA761174 |
| RxNorm concept | 2539972 |
| Package sizes listed | 1 |
| Marketed since | April 2021 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.